Our results demonstrate that NLRP3 inflammasome is the primary target for the action of TR in the mouse models of inflammation‐associated diseases, at least in type 2 diabetes and gouty arthritis. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.